ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Latest Poll: More Than One-Third of Moderate Voters Do Not Trust Federal Health Agencies

By: Get News
The poll of over 1,000 registered voters revealed that more than half oppose government vaccine mandates and believe the public should have the right to sue vaccine manufacturers for injuries.

WASHINGTON, D.C. - A recent poll of 1,005 national voters shows that 59% trust health agencies such as the CDC and FDA, while 36% do not, leaving only 5% undecided. Children's Health Defense commissioned the online national survey, which was conducted in November 2024 by Zogby Strategies. The overall margin of sampling error is +/- 3.2 percentage points, with subgroups having higher margins.

Federal health agencies have long faced a lack of trust from the American public. However, this distrust goes deeper than simple ideological bias. The polarization seen during and after the COVID-19 pandemic has widened the trust gap between the government and the public. The survey shows that even among moderates, 33% do not trust the CDC and FDA, while 60% do trust them, leaving 7% undecided.

In the survey, 41% of voters believe the government mishandled or failed to handle the COVID-19 pandemic, compared to 53% who think it managed the pandemic well or did the best it could. However, only 13% of respondents said the government handled the pandemic effectively.

The poll also showed that fewer than half of the surveyed individuals supported government vaccine mandates. The group most opposed to vaccine mandates consisted of 45- —to 64-year-olds, of whom 55% oppose them.

Additionally, more than half (57%) of poll respondents believed that vaccine manufacturers should lose their immunity from legal action and expressed that the public should be able to sue if a vaccine caused them harm.

“This data highlights a significant loss of trust in our regulatory agencies. Allowing this distrust to persist will further undermine the public’s confidence in our healthcare organizations,” said Mary Holland, Esq., CEO of Children’s Health Defense. “We must emphasize that if the government wishes to regain credibility, it must recognize the realities of vaccines. Until that happens, Americans are less likely to heed their guidance, and the remaining public faith in these institutions will ultimately vanish.”

John Zogby Strategies, an independent market research firm, conducted an online national poll of 1,005 registered likely voters for the 2024 general election, with an overall margin of sampling error of +/- 3.2 percentage points. Subgroups exhibit higher error margins. Secure invitations were sent to a random sample of our nationwide panel of approximately 15 million adults via email, text-to-web, and API. Survey participants were screened based on age, voter registration status, and likelihood to vote. Minor weights were applied to ensure that the sample accurately represented the population’s age, education level, gender, political affiliation, race, and geographic region.

More information about the poll can be found here.

Review the complete polling data here.

Children’s Health Defense® is a 501(c)(3) non-profit organization. Our mission is ending childhood health epidemics by eliminating toxic exposure. We will restore and protect the health of children by eliminating environmental exposures, holding responsible parties accountable, and establishing safeguards to prevent future harm of children’s health. Protecting Children. Exposing Harms. Seeking Justice.

For more information or to donate to CHD, visit ChildrensHealthDefense.org.

Media Contact
Company Name: Children's Health Defense
Contact Person: Press
Email: Send Email
Phone: 202-417-6971
Address:852 Franklin Ave., Suite 511
City: Franklin Lakes
State: New Jersey
Country: Colombia
Website: https://childrenshealthdefense.org

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.